Target intelligence / Profile preview

Gap junction protein beta 6 (GJB6 (Connexin 30, often abbreviated as Cx30))

Target
GJB6 (Connexin 30, often abbreviated as Cx30)
Molecular classification
Gap junction protein, Connexin family, Ion channel (forms channels allowing passive ion and metabolite movement between cells)
01

Overview

Gap junction protein beta 6, most commonly referred to as connexin 30 (Cx30), is a member of the connexin protein family that assembles into hexameric structures called connexons, which pair with connexons in neighboring cells to form gap junction channels. These channels enable the passive diffusion of ions (such as potassium) and small signaling molecules (<1 kDa) directly between the cytoplasm of adjacent cells, facilitating metabolic and electrical coordination. Connexin 30 is highly expressed in the inner ear (critical for hearing by recycling potassium ions), brain (in astrocytes, influencing synaptic activity and network dynamics), skin, hair follicles, and nail beds. Genetic defects in *GJB6* cause Clouston syndrome (hidrotic ectodermal dysplasia) and contribute to inherited deafness. *GJB6* is essential for epithelial and neuronal tissue homeostasis, and its disruption leads to multisystem disease involving hearing, skin, and nail abnormalities

Other names
Connexin 30 (Cx30)GJB6CX30EDH (Ectodermal dysplasia, hidrotic)HED (Hidrotic ectodermal dysplasia)DFNA3 (Deafness, nonsyndromic, autosomal dominant 3)ED2 (Ectodermal dysplasia 2)
02

Mechanism of action

Not directly applicable (no specific drugs); in principle, modulators of gap junctions could disrupt or potentiate cell-cell communication by altering channel opening, closure, or assembly

03

Biological functions

Cell-cell communicationDirect intercellular signalingPotassium ion recycling (especially in the cochlea)Regulation of tissue homeostasis (skin, brain, cochlea)Support of hearing (via potassium ion recycling in the inner ear)Network formation in astrocytes (in the brain)
04

Disease associations

Hereditary deafness (syndromic and nonsyndromic)Clouston syndrome (hidrotic ectodermal dysplasia 2)Disorders of skin, hair, and nails (due to ectodermal dysplasia)Other rare congenital disorders involving cell junctions
05

Safety considerations

Not directly applicable; however, because gap junctions are critical in tissue homeostasis, attempts to pharmacologically modulate their function can carry risks of impaired cell communication, tissue repair, or unexpected effects in heart, brain, or skin
06

Interacting drugs

None specifically reported (as of current knowledge, no approved drugs directly target gap junction protein beta 6/Cx30; however, pharmacological gap junction inhibitors or enhancers may affect its function indirectly, but are not specific to this connexin)
07

Biomarkers

Mutations or deletions in *GJB6* serve as genetic biomarkers for Clouston syndrome and certain forms of hereditary non-syndromic deafness (DFNA3)

Beyond the preview

Go deeper on Gap junction protein beta 6 (GJB6 (Connexin 30, often abbreviated as Cx30)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gap junction protein beta 6 (GJB6 (Connexin 30, often abbreviated as Cx30)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call